National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

Lee, 2008, Recognizing and managing chronic graft-versus-host disease, 134 Lee, 2003, Chronic graft-versus-host disease, Biol Blood Marrow Transplant, 9, 215, 10.1053/bbmt.2003.50026 Flowers, 2009, Clinical manifestations and natural history, 56 Filipovich, 2005, National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report, Biol Blood Marrow Transplant, 11, 945, 10.1016/j.bbmt.2005.09.004 Flowers, 2011, Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria, Blood, 117, 3214, 10.1182/blood-2010-08-302109 Baird, 2013, National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis, Biol Blood Marrow Transplant, 19, 632, 10.1016/j.bbmt.2013.01.013 Vigorito, 2009, Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD, Blood, 114, 702, 10.1182/blood-2009-03-208983 Jacobsohn, 2012, Correlation between NIH composite skin score, patient reported skin score, and outcome: results from the Chronic GVHD Consortium, Blood, 120, 2545, 10.1182/blood-2012-04-424135 Pidala, 2012, Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study, Haematologica, 97, 451, 10.3324/haematol.2011.055186 Pidala, 2011, Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium, Blood, 117, 4651, 10.1182/blood-2010-11-319509 Arai, 2011, Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria, Blood, 118, 4242, 10.1182/blood-2011-03-344390 Pidala, 2011, Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium, Haematologica, 96, 1528, 10.3324/haematol.2011.046367 Arora, 2013, Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study, Leukemia, 27, 1196, 10.1038/leu.2012.292 Kuzmina, 2012, Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study, Leukemia, 26, 746, 10.1038/leu.2011.257 Inamoto, 2012, Validation of measurement scales in ocular graft-versus-host disease, Ophthalmology, 119, 487, 10.1016/j.ophtha.2011.08.040 Pidala, 2013, Analysis of gastrointestinal and hepatic chronic graft-versus-host disease manifestations on major outcomes: a Chronic Graft-Versus-Host Disease Consortium study, Biol Blood Marrow Transplant, 19, 784, 10.1016/j.bbmt.2013.02.001 Jagasia, 2012, Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial, Bone Marrow Transplant, 47, 1350, 10.1038/bmt.2011.261 Cho, 2009, Feasibility of NIH consensus criteria for chronic graft-versus-host disease, Leukemia, 23, 78, 10.1038/leu.2008.276 Arora, 2009, New classification of chronic GVHD: added clarity from the consensus diagnoses, Bone Marrow Transplant, 43, 149, 10.1038/bmt.2008.305 Pérez-Simón, 2008, Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the National Institutes Health Scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy, Biol Blood Marrow Transplant, 14, 1163, 10.1016/j.bbmt.2008.07.015 Herzberg, 2010, Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 16, 1707, 10.1016/j.bbmt.2010.05.018 Inamoto, 2014, Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD, Bone Marrow Transplant, 49, 532, 10.1038/bmt.2013.225 Inamoto, 2014, Assessment of joint and fascia manifestations in chronic graft-versus-host disease, Arthritis Rheumatol, 66, 1044, 10.1002/art.38293 Jagasia, 2007, Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria, Biol Blood Marrow Transplant, 13, 1207, 10.1016/j.bbmt.2007.07.001 Arora, 2011, Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis, Blood, 117, 6714, 10.1182/blood-2010-12-323824 Inamoto, 2013, Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease, Blood, 121, 2340, 10.1182/blood-2012-11-465583 Jacobs, 2012, Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria, Bone Marrow Transplant, 47, 1470, 10.1038/bmt.2012.56 Ogawa, 2013, International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I), Sci Rep, 3, 3419, 10.1038/srep03419 Zantomio, 2006, Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management, Bone Marrow Transplant, 38, 567, 10.1038/sj.bmt.1705487 Marks, 2011, German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD, Br J Dermatol, 165, 18, 10.1111/j.1365-2133.2011.10360.x Smith Knutsson, 2014, Genital chronic graft-versus-host disease in females: a cross-sectional study, Biol Blood Marrow Transplant, 20, 806, 10.1016/j.bbmt.2014.02.016 Hirsch, 2012, Female genital chronic graft-versus-host disease: importance of early diagnosis to avoid severe complications, Transplantation, 93, 1265, 10.1097/TP.0b013e31824f3dcd Spinelli, 2003, Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation, Haematologica, 88, 1163 Shanis, 2012, Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management (Review), Semin Hematol, 49, 83, 10.1053/j.seminhematol.2011.10.002 Mueller, 2013, Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients, Biol Blood Marrow Transplant, 19, 1574, 10.1016/j.bbmt.2013.07.010 Marks, 2011, Genital mucosa in men is a target of chronic graft-versus-host disease with serious impact on quality of life, Bone Marrow Transplant, 46 Brook, 2014, Pancreatic atrophy in patients with chronic graft-versus-host disease, Abdom Imaging, 39, 342, 10.1007/s00261-013-0072-y Williams, 2009, Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation, JAMA, 302, 306, 10.1001/jama.2009.1018 Hildebrandt, 2011, Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD (Review), Bone Marrow Transplant, 46, 1283, 10.1038/bmt.2011.35 Hankinson, 1999, Spirometric reference values from a sample of the general U.S. population, Am J Respir Crit Care Med, 159, 179, 10.1164/ajrccm.159.1.9712108 Gálban, 2012, Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression, Nat Med, 18, 1711, 10.1038/nm.2971 Palmer, 2014, Pulmonary symptoms measured by the National Institutes of Health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease, Biol Blood Marrow Transplant, 20, 337, 10.1016/j.bbmt.2013.11.025 Pidala, 2013, Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium, Biol Blood Marrow Transplant, 19, 967, 10.1016/j.bbmt.2013.03.014 Aki, 2014, Confounding factors affecting the National Institutes of Health (NIH) chronic GVHD organ-specific score and global severity, Biol Blood Marrow Transplant, 20, S265, 10.1016/j.bbmt.2013.12.448 Jacobsohn, 2011, Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease, Blood, 118, 4472, 10.1182/blood-2011-04-349068 Lee, 2002, Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse, Blood, 100, 406, 10.1182/blood.V100.2.406 Pavletic, 2005, Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation, Blood, 106, 3308, 10.1182/blood-2005-04-1614 Akpek, 2003, Performance of a new clinical grading system for chronic graft-versus-host disease: a multi-center study, Blood, 102, 802, 10.1182/blood-2002-10-3141 Stewart, 2004, Duration of immunosuppressive treatment for chronic graft-versus-host disease, Blood, 104, 3501, 10.1182/blood-2004-01-0200 Sullivan, 1988, Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation, Blood, 72, 546, 10.1182/blood.V72.2.546.546 Wingard, 1989, Predictors of death from chronic graft versus host disease after bone marrow transplantation, Blood, 74, 1428, 10.1182/blood.V74.4.1428.1428